|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
06990 SKB BIO-B
Nominal 
425.800 +4.800 (+1.140%) Profitability Analysis
| 2025/12 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| ROAA (%) | -7.448% | -6.860% | -25.501% | -68.224% | -109.452% |
| ROAE (%) | -9.344% | -9.463% | N/A | N/A | 33.655% |
| Return on Capital Employed (%) | -7.664% | -7.714% | -23.925% | N/A | N/A |
Margin Analysis
| 2025/12 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| Gross Profit Margin (%) | 71.858% | 65.889% | 49.282% | 65.566% | 36.498% |
| EBITDA Margin (%) | -16.989% | -4.218% | -22.947% | -43.860% | -2336.167% |
| Pre-tax Profit Margin (%) | -17.288% | -7.374% | -30.360% | -70.574% | -2752.908% |
| Net Profit Margin (%) | -18.561% | -13.800% | -37.269% | -76.636% | -2752.908% |
Liquidity Analysis
| 2025/12 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| Current Ratio (X) | 5.126 X | 4.313 X | 2.529 X | 0.080 X | 0.087 X |
| Quick Ratio (X) | 4.886 X | 4.176 X | 2.472 X | 0.067 X | 0.072 X |
Leverage Analysis
| 2025/12 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| Total Liabilities / Total Assets(%) | 18.727% | 22.478% | 33.628% | 424.845% | 425.218% |
| Total Debt / Total Assets (%) | 1.477% | 2.970% | 1.707% | 303.515% | 294.097% |
| Net Debt / Total Assets (%) | -52.690% | -28.345% | -41.851% | 294.155% | 284.035% |
| Total Debt / Shareholders' Funds (%) | 1.817% | 3.831% | 2.572% | N/A | N/A |
| Long Term Debt / Shareholders' Funds (%) | 0.905% | 2.566% | 0.237% | N/A | N/A |
| Net Debt / Shareholders' Funds (%) | -64.831% | -36.563% | -63.055% | N/A | N/A |
| Net Cash / (Debt) ($) | 3.155B | 1.210B | 1.469B | (2.921B) | (2.309B) |
| Net Cash / (Debt) per share ($) | 13.531 | 5.323 | 6.701 | -- | -- |
| Total Debt / Capital Employed (%) | 1.775% | 3.665% | 2.497% | N/A | N/A |
| Interest Coverage Ratio (X) | N/A | N/A | N/A | N/A | N/A |
Efficiency Analysis
| 2025/12 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| Inventory Turnover (Day) | 110.750 Day | 48.030 Day | 27.018 Day | 68.141 Day | 902.035 Day |
| Receivables Turnover (Day) | 13.508 Day | 10.922 Day | N/A | N/A | 1.649 Day |
| Payables Turnover (Day) | 61.315 Day | 62.825 Day | 63.261 Day | 64.248 Day | 1490.422 Day |
| Remarks: | Real time quote last updated: 25/03/2026 18:00 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB -381,971 |
| %Change | 43.186% |
| EPS / (LPS) | RMB -1.660 |
| NBV Per Share (¥) | RMB 20.872 |